Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 61Gastrointestinal 20Genitourinary 13Thoracic 12Plasma cell 9Lymphoid 7Head & Neck 7CNS 5Tumor-Agnostic 3Other 3Gynecologic 3Other hematologic neoplasm 2Classical hematology 2Sarcoma 1NET 1Myeloid 1Endocrine 1Dermatologic 1

Conditions

Sarcoma 1Febrile Neutropenia 1Cross Infection 1

Interventions

Radiotherapy 220Doxorubicin 210Cyclophosphamide 210Temozolomide 182Ifosfamide 121Filgrastim 111Imatinib Mesylate 104Etoposide 101Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 80Irinotecan 79pembrolizumab 75Radiation 69Carboplatin 65Methotrexate 62pazopanib 61Nivolumab 58Cisplatin 58fludarabine phosphate 57Peripheral Blood Stem Cell Transplantation 57Surgical Procedures, Operative 56Specimen Handling 56Trabectedin 52Docetaxel 50Biopsy 50Busulfan 49Melphalan 46Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acupuncture Therapy × Sarcoma × Clear all
NCT06500715 2026-04-29

Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma

Shaare Zedek Medical Center

Phase NA Not yet recruiting
60 enrolled
Classical hematologySarcoma

Cross Infection, Sarcoma, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡